Linchong Su

1.2k total citations
37 papers, 786 citations indexed

About

Linchong Su is a scholar working on Immunology, Rheumatology and Molecular Biology. According to data from OpenAlex, Linchong Su has authored 37 papers receiving a total of 786 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Immunology, 20 papers in Rheumatology and 7 papers in Molecular Biology. Recurrent topics in Linchong Su's work include Systemic Lupus Erythematosus Research (16 papers), T-cell and B-cell Immunology (6 papers) and Cytokine Signaling Pathways and Interactions (6 papers). Linchong Su is often cited by papers focused on Systemic Lupus Erythematosus Research (16 papers), T-cell and B-cell Immunology (6 papers) and Cytokine Signaling Pathways and Interactions (6 papers). Linchong Su collaborates with scholars based in China, United States and Australia. Linchong Su's co-authors include An‐Fang Huang, Wang‐Dong Xu, Xiaoyan Liu, Hong Jia, Xingyou Liu, Yi Liu, Yi Liu, Yi Zhao, Yubin Luo and Qiuping Zhang and has published in prestigious journals such as Frontiers in Immunology, Journal of Cellular Physiology and Medicine.

In The Last Decade

Linchong Su

36 papers receiving 774 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Linchong Su China 14 303 234 183 102 100 37 786
Xiao‐Ke Yang China 19 275 0.9× 367 1.6× 289 1.6× 124 1.2× 191 1.9× 54 969
Chaokui Wang China 17 210 0.7× 251 1.1× 250 1.4× 90 0.9× 54 0.5× 33 844
Jacob Sode Denmark 11 235 0.8× 195 0.8× 192 1.0× 53 0.5× 73 0.7× 18 672
Florian Meier Germany 12 170 0.6× 204 0.9× 266 1.5× 108 1.1× 70 0.7× 42 823
R. Brizzolara Italy 16 353 1.2× 158 0.7× 152 0.8× 110 1.1× 28 0.3× 52 990
Safa Barış Türkiye 17 512 1.7× 199 0.9× 72 0.4× 81 0.8× 38 0.4× 87 951
Salma Kotti France 10 359 1.2× 265 1.1× 85 0.5× 133 1.3× 42 0.4× 25 965
Jennifer McCormick Ireland 12 311 1.0× 232 1.0× 217 1.2× 138 1.4× 101 1.0× 12 732
Rafael S. Grajewski Germany 15 395 1.3× 118 0.5× 174 1.0× 70 0.7× 20 0.2× 37 1.0k
Sara Mohamed Egypt 8 276 0.9× 87 0.4× 195 1.1× 79 0.8× 39 0.4× 39 566

Countries citing papers authored by Linchong Su

Since Specialization
Citations

This map shows the geographic impact of Linchong Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linchong Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linchong Su more than expected).

Fields of papers citing papers by Linchong Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linchong Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linchong Su. The network helps show where Linchong Su may publish in the future.

Co-authorship network of co-authors of Linchong Su

This figure shows the co-authorship network connecting the top 25 collaborators of Linchong Su. A scholar is included among the top collaborators of Linchong Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linchong Su. Linchong Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Qinghong, Yuqing Zeng, Ruiling Feng, et al.. (2025). Evaluating the therapeutic potential of tofacitinib in Sjögren’s disease: a comprehensive clinical and immunological assessment. Lara D. Veeken. 64(11). 5899–5910. 2 indexed citations
2.
Su, Linchong, et al.. (2025). Transcriptomic Analysis and Experimental Verification of Ferroptosis Signature Genes in Osteoarthritis. International Journal of Rheumatic Diseases. 28(1). e70083–e70083. 1 indexed citations
3.
Xu, Wang‐Dong, et al.. (2024). Development and external validation of a prediction model for interstitial lung disease in systemic lupus erythematosus patients: A cross-sectional study. Seminars in Arthritis and Rheumatism. 69. 152556–152556. 1 indexed citations
4.
Huang, Xia, et al.. (2023). Bioinformatics analyses of gene expression profile to identify pathogenic mechanisms for COVID-19 infection and cutaneous lupus erythematosus. Frontiers in Immunology. 14. 1268912–1268912. 2 indexed citations
5.
6.
Xu, Wang‐Dong, Linchong Su, Lu Fu, et al.. (2022). IL-38, a potential therapeutic agent for lupus, inhibits lupus progression. Inflammation Research. 71(7-8). 963–975. 8 indexed citations
7.
Su, Linchong, et al.. (2021). Bioinformatics analyses of gene expression profile identify key genes and functional pathways involved in cutaneous lupus erythematosus. Clinical Rheumatology. 41(2). 437–452. 7 indexed citations
8.
Xu, Wang‐Dong, et al.. (2021). Association of CD40 Gene Polymorphisms With Systemic Lupus Erythematosus and Rheumatoid Arthritis in a Chinese Han Population. Frontiers in Immunology. 12. 642929–642929. 6 indexed citations
9.
Tong, Yanli, Linlin Zheng, Pingying Qing, et al.. (2020). Oral Microbiota Perturbations Are Linked to High Risk for Rheumatoid Arthritis. Frontiers in Cellular and Infection Microbiology. 9. 475–475. 73 indexed citations
10.
Xie, Qiang, Wang‐Dong Xu, Min Pan, et al.. (2020). Association of IL-35 expression and gene polymorphisms in rheumatoid arthritis. International Immunopharmacology. 90. 107231–107231. 11 indexed citations
11.
Zhong, Jixin, Guifen Shen, Huiqin Yang, et al.. (2020). COVID-19 in patients with rheumatic disease in Hubei province, China: a multicentre retrospective observational study. The Lancet Rheumatology. 2(9). e557–e564. 79 indexed citations
12.
Xu, Wang‐Dong, Xiaoyan Liu, Linchong Su, & An‐Fang Huang. (2020). Association of MASP2 levels and MASP2 gene polymorphisms with systemic lupus erythematosus. Journal of Cellular and Molecular Medicine. 24(18). 10432–10443. 10 indexed citations
13.
Xu, Wang‐Dong, et al.. (2019). Biology of IL-36 Signaling and Its Role in Systemic Inflammatory Diseases. Frontiers in Immunology. 10. 2532–2532. 92 indexed citations
14.
Su, Linchong, et al.. (2019). Altered expression of circular RNA in primary Sjögren’s syndrome. Clinical Rheumatology. 38(12). 3425–3433. 21 indexed citations
15.
Xu, Wang‐Dong, et al.. (2018). Plasma interleukin-38 in patients with rheumatoid arthritis. International Immunopharmacology. 65. 1–7. 48 indexed citations
16.
Li, Yanhong, Yuanyuan Zhang, Ting Liu, et al.. (2018). High fat diet-induced obesity exacerbates hematopoiesis deficiency and cytopenia caused by 5-fluorouracil via peroxisome proliferator-activated receptor γ. Experimental Hematology. 60. 30–39.e1. 10 indexed citations
17.
Xu, Wang‐Dong, et al.. (2017). Analysis of blood glucose distribution characteristics in a health examination population in Chengdu (2007–2015). Medicine. 96(49). e8765–e8765. 5 indexed citations
18.
Xu, Wang‐Dong, Linchong Su, Pingying Qing, et al.. (2017). Elevated levels of TL1A are associated with disease activity in patients with systemic sclerosis. Clinical Rheumatology. 36(6). 1317–1324. 13 indexed citations
20.
Xu, Wang‐Dong, Linchong Su, Qibing Xie, Yi Zhao, & Yi Liu. (2016). Interleukin-2-inducible T-cell kinase expression and relation to disease severity in systemic lupus erythematosus. Clinica Chimica Acta. 463. 11–17. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026